
Lumateperone NEW
Price | $33 | $48 | $64 |
Package | 10mg | 25mg | 50mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2025-04-29 |
Product Details
Product Name: Lumateperone | CAS No.: 313368-91-1 |
Purity: 99.77% | Supply Ability: 10g |
Release date: 2025/04/29 |
Product Introduction
Bioactivity
Name | Lumateperone |
Description | Lumateperone (ITI 722) is a 5HT2A receptor antagonist and a dopamine receptor phosphoprotein modulator (DPPM). |
In vivo | ITI-722 was evaluated in the rat quipazine head twitch model induced by quipazine which is a 5-HT2A agonist, ITI-722 have ED50 values of 0.12 mg/kg. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 3.93 mg/mL (9.99 mM), Sonication is recommended. |
Keywords | Serotonin Receptor | schizophrenia | presynaptic D2 receptor | postsynaptic D2 receptor | Lumateperone | ITI-722 | ITI 007 | Inhibitor | inhibit | Dopamine Receptor | dopamine D1 receptor | 5-hydroxytryptamine Receptor | 5HTReceptor | 5-HT2A | 5-HT Receptor | 5HT Receptor |
Inhibitors Related | Serotonin hydrochloride | Alverine citrate | Olanzapine | Dapoxetine hydrochloride | Clozapine N-Oxide | D-Menthol | Amitriptyline hydrochloride | Cloperastine hydrochloride | Trazodone hydrochloride | Mianserin hydrochloride | Fluoxetine hydrochloride | Cinchonidine |
Related Compound Libraries | Failed Clinical Trials Compound Library | Pain-Related Compound Library | Anti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/10mg |
VIP2Y
|
ShenZhen H&D Pharmaceutical Technology Co., LTD
|
2025-03-26 | |
$0.00/1kg |
VIP1Y
|
Wuhan Circle Star Chem-medical Technology Co.,Ltd
|
2025-01-03 | |
$0.00/1gram |
VIP3Y
|
Chengdu Aupone Pharmaceutical Co.Ltd.
|
2024-03-18 | |
$0.00/1g |
VIP3Y
|
shandong perfect biotechnology co.ltd
|
2023-08-01 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY